Grace Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Grace Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Grace Therapeutics Inc.
Rating: 1.28500
Author: Trendlyne DVM scores

about

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for t...

2.16 -0.03 (-1.37%)

58.30% Fall from 52W High

268.4K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.0 / 100

Technically Neutral

36.4 / 100

No estimates available

Grace Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Grace Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for t...

58.30% Fall from 52W High

SWOT Analysis

Grace Therapeutics Inc Live Price Chart